Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Total Debt / Equity

Alexion Pharm Inc Total Debt / Equity Chart (ALXN)

Alexion Pharm Inc annual/quarterly Total Debt / Equity from 2010 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Alexion Pharm Inc Total Debt / Equity for the quarter ending September 09, 2020 was $27m a 6.59% increase of 2m year over year
  • Alexion Pharm Inc Total Debt / Equity for the last 12 months ending September 09, 2020 was $27m a 6.59% increase of 2m year over year
  • Alexion Pharm Inc Annual Total Debt / Equity for 2019 was $25m a -40.42% decrease of -10m from 2018
  • Alexion Pharm Inc Annual Total Debt / Equity for 2018 was $35m a -3.60% decrease of -1m from 2017
  • Alexion Pharm Inc Annual Total Debt / Equity for 2017 was $36m a -3.79% decrease of -1m from 2016
Other Ratios Metrics:
  • Alexion Pharm Inc Total Debt / Capital for the quarter ending December 12, 2018 was $26m a -0.19% decrease of 0m year over year
  • Alexion Pharm Inc Other Liabilities for the quarter ending December 12, 2018 was $730m a -2.27% decrease of -17m year over year
View Chart On Koyfin

Quarterly ALXN Total Debt / Equity Data

09/2020$27m
06/2020$27m
03/2020$24m
12/2019$25m
09/2019$28m
06/2019$28m
03/2019$30m
12/2018$35m
09/2018$35m
06/2018$37m

Annual ALXN Total Debt / Equity Data

2019$25m
2018$35m
2017$36m
2016$38m
2015$43m
2014$5m
2013$6m
2012$8m
2010$1m